Integrated BioPharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1996
Net Income	-0.03	3.84	8.01	4.11	1.69	0.68	2.35	0.96	0.74	0.13	Upgrade
Depreciation & Amortization	1.15	0.83	0.83	0.77	0.77	0.35	0.39	0.35	0.41	0.39	Upgrade
Share-Based Compensation	0.32	0.37	0.23	0.06	0.14	0.01	0.05	0.03	0.1	0	Upgrade
Other Operating Activities	-0.21	-0.95	-6.02	-3.6	-2.28	0.13	-2.39	-1.93	-1.36	1.36	Upgrade
Operating Cash Flow	1.23	4.09	3.05	1.34	0.33	1.17	0.4	-0.59	-0.11	1.88	Upgrade
Operating Cash Flow Growth	-69.89%	34.13%	127.78%	308.23%	-71.92%	194.21%	-	-	-	-	Upgrade
Capital Expenditures	-0.12	-0.49	-0.3	-0.21	-0.41	-0.25	-0.33	-0.11	-0.24	-0.18	Upgrade
Acquisitions	0	0.02	0.1	0.1	-0.01	-0	0	0	0.08	0	Upgrade
Change in Investments	-0.01	-	-0.29	-0.1	-0.02	-	-	-	-	-	Upgrade
Other Investing Activities	0.01	-	0.29	0.1	0.02	0.01	-	0	-	-	Upgrade
Investing Cash Flow	-0.11	-0.47	-0.2	-0.11	-0.42	-0.24	-0.33	-0.11	-0.16	-0.18	Upgrade
Common Stock Issued	0	0.03	0.1	0.1	0.02	0	0	0	0	0	Upgrade
Other Financing Activities	-0.14	-3.54	-3.14	-1.4	0.32	-0.83	-0.33	1.03	-0.11	-1.3	Upgrade
Financing Cash Flow	-0.14	-3.51	-3.04	-1.3	0.34	-0.83	-0.33	1.03	-0.11	-1.3	Upgrade
Net Cash Flow	0.99	0.12	-0.19	-0.07	0.25	0.1	-0.26	0.32	-0.38	0.4	Upgrade
Free Cash Flow	1.12	3.61	2.76	1.13	-0.09	0.92	0.07	-0.7	-0.35	1.7	Upgrade
Free Cash Flow Growth	-69.04%	30.85%	144.89%	-	-	1215.71%	-	-	-	-	Upgrade
Free Cash Flow Margin	2.20%	6.41%	4.33%	2.13%	-0.17%	2.11%	0.15%	-1.67%	-0.93%	5.03%	Upgrade
Free Cash Flow Per Share	0.04	0.11	0.09	0.04	-0.00	0.03	0.00	-0.03	-0.01	0.08	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.